A Registry Program for Familial Gastric Cancer Patients Referred to Cancer Institute of Iran

  • Etemadi, Mehrnoosh (Students Scientific Research Center (SSRC) & Exceptional Talent Development Center (ETDC)) ;
  • Pourian, Mandana (Students Scientific Research Center (SSRC) & Exceptional Talent Development Center (ETDC)) ;
  • Shakib, Asyeh (Students Scientific Research Center (SSRC) & Exceptional Talent Development Center (ETDC)) ;
  • Sabokbar, Tayebeh (Genetics group, Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences (TUMS)) ;
  • Peyghanbari, Vahideh (Genetics group, Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences (TUMS)) ;
  • Shirkoohi, Reza (Genetics group, Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences (TUMS))
  • 발행 : 2014.03.01


Background: Gastric cancer is the second most common cause of cancer death. It has a poor prognosis with only 5-10% of hereditary etiology. If it is diagnosed, it could be helpful for screening the other susceptible members of a family for preventive procedures. Usually it is identified by symptoms such as presence of cancer in different members of family, some special type of pathology such as diffused adenocarcinoma, having younger age and multiple cancer syndromes. Hence, designing a registry program can be a more practical way to screen high risk families for a preventive program. Materials and Methods: Based on the inclusion criteria, a questionnaire was prepared. After pilot on a small number of patients, the actual data was collected from 197 patients and processed in SPSS 16.0. Results: Totally, 11.8% of the patients were younger than 45 years old. Blood type 'A' was dominant and males had a higher risk behavior with higher consumption of unhealthy food. Adenocarcinoma was reported in majority of cases. 21.8% of the patients had the including criteria for familial gastric cancer (FGC). Conclusions: The high percentage of FGC population compared to the other studies have revealed a need to design an infrastructural diagnostic protocol and screening program for patients with FGC, plus preventive program for family members at risk which could be done by a precise survey related to frequency and founder mutations of FGC in a national registry program.


  1. Al-Refaie W, Hu C, Pisters P, Chang G (2011). Gastric adenocarcinoma in young patients: a population-based appraisal. Ann Surg Oncol, 18, 2800-7.
  2. Barber M, Fitzgerald R, Caldas C (2006). Familial gastric cancer-aetiology and pathogenesis. Best Pract Res Clin Gastroenterol, 20, 721-34.
  3. Behnampour N, HajizadehE, Zayeri F, Semnani S (2014). Modeling of influential predictors of gastric cancer incidence rates in Golestan province, North Iran. Asian Pac J Cancer Prev, 15, 1111-7.
  4. Brose M, Smyrk T, Weber B, et al (1999). Familial gastric cancer: overview and guidelines for management. J Med Genet, 36, 873-80.
  5. Chen Y, Kingham K, Ford J, et al (2011). A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol, 18, 2594-8.
  6. Edgren G, Hjalgrim H, Rostgaard K, et al (2010). Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol, 172, 1280-5.
  7. Everatt R, Tamosiunas A, Kuzmickiene I, et al (2012).Alcohol consumption and risk of gastric cancer: a cohort study of men in Kaunas, Lithuania, with up to 30 years follow-up. BMC Cancer, 15, 475.
  8. Goldman L, Schafer A (2012). Chapter 198. Neoplasms of the esophagus and stomach, Philadelphia: Elsvier Saunders.
  9. Hajmanoochehri F, Mohammadi N, Nasirian N, Hosseinkhani M (2013). Patho-epidemiological features of esophageal and gastric cancers in an endemic region: a 20-year retrospective study. Asian Pac J Cancer Prev, 14, 3491-7.
  10. Howlader N, Noone A, Krapcho M, et al (2011) (1975-2009 (Vintage 2009 Populations)) SEER Cancer Statistics Review. National Cancer Institute, Bethesda, MD.
  11. Jacobs E, Thompson P, Martinez M (2007). Diet, gender, and colorectal neoplasia. J Clin Gastroenterol, 41, 731-46.
  12. Jiang Y, Wan Y, Wang Z, et al (2004). Germline E-cadherin gene mutation screening in familial gastric cancer kindreds. Zhonghua Wai Ke Za Zhi, 42, 914-7.
  13. Kang JM, Shin DW, Kwon YM, et al (2011). Stomach cancer screening and preventive behaviors in relatives of gastric cancer patients. World J Gastroenterol, 17, 3518-25.
  14. Kato M, Asaka M (2012). Recent development of gastric cancer prevention. Jpn J Clin Oncol, 42, 987-94.
  15. Kaurah P, Huntsman D (2011). Hereditary Diffuse Gastric Cancer. In: Pagon R, Bird T, Dolan C, Stephens K, Adam M, editors. GeneReviews. Seattle: University of Washington.
  16. Keller G, Vogelsang H, Becker I, et al (1999). Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol, 155, 337-42.
  17. Kolahdoozan S, Sadjadi A, Radmard A, Khademi H (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
  18. Kumar EA (2010). Pathologic Basis of Disease. 8th ed.: Saunders Elsevier, 2010.
  19. Mousavi S, Gouya M, Ramazani R, et al (2009) Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  20. Petrucelli N, Daly M, Feldman G (2011). BRCA1, BRCA2 Hereditary Breast and Ovarian Cancer In: Pagon R, Bird T, Dolan C, Stephens K, Adam M, editors. GeneReviews. Seattle University of Washington.
  21. Richards F, McKee S, Rajpar M, et al (1999). Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet, 8, 607-10.
  22. Rustgi A (2012). Neoplasms of the Stomach. In: Goldman L, Ausiello D, editors. Cecil Medicine. 24 ed. Philadelphia, Pa: Saunders Elsevier. p. 1272-8.
  23. Sabokbar T, Khajeh E, Taghdiri F, Peyghambari V, Shirkoohi R (2012). Familial breast cancer registry program in patients referred to the Cancer Institute of Iran. Asian Pac J Cancer Prev, 14, 2675-9.
  24. Scheuner M, McNeel T, Freedman A (2010). Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med, 12, 726-35.
  25. Strnad M (2010). Salt and cancer. Acta Med Croatica, 64, 159-61.
  26. Wang X, Terry P, Yan H (2010). Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol, 15, 204-13.
  27. Winawer S (2005). Gastric cancer: Worldwide burden and prevention opportunities. Chin J Dig Dis, 6, 107-9.
  28. Zare A, Mahmoodi M, Mohammad K, et al (2013). Survival analysis of patients with gastric cancer undergoing surgery at the Iran Cancer Institute: a method based on multi-state models. Asian Pac J Cancer Prev, 14, 6369-73.
  29. Zhang Y, Shi J, Yu H, et al (2012). Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus. World J Gastroenterol, 18, 3602-9.

피인용 문헌

  1. Factors Predicting Survival of Patients with Gastric Cancer vol.15, pp.14, 2014,